Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Critical Reviews in Immunology|October 26, 1999
Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-gamma2S Ben-Efraim, Y Keisari, R Ophir, et al.
International Journal of Cancer|April 22, 1991
Therapeutic effectiveness against MOPC-315 plasmacytoma of low or high doses of the synthetic thymic hormone THF-gamma 2 in combination with an "immunomodulating" or a "non-immunomodulating" drugR Ophir, M Pecht, Y Burstein, et al.
International Archives of Allergy and Applied Immunology|January 1, 1979
Effect of the MER tubercle bacillus fraction on the responsiveness of mice to T-independent antigensS Ben-Efraim, R Ophir, R Teitelbaum, et al.
International Journal of Immunopharmacology|January 1, 1990
THF-gamma 2, a synthetic thymic hormone, increases effectiveness of combined chemotherapy and immunotherapy against RPC-5 murine plasmacytomaR Ophir, M Pecht, E H Relyveld, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytomaR Ophir, M Pecht, D Halperin, et al.
International Journal of Cancer|June 15, 1990
A synthetic thymic hormone, THF-gamma 2, repairs immunodeficiency of mice cured of plasmacytoma by melphalanR Ophir, M Pecht, G Rashid, et al.
Marine Biotechnology (New York, N.Y.)|January 24, 2008
Pollution-affected fish hepatic transcriptome and its expression patterns on exposure to cadmiumM Auslander, Y Yudkovski, V Chalifa-Caspi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanomaR Ophir, G Moalem, M Pecht, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Inhibition of murine Lewis lung carcinoma metastases by combined chemotherapy and intranasal THF-gamma 2 immunotherapyG Rashid, R Ophir, M Pecht, et al.
Immunopharmacology and Immunotoxicology|May 1, 1996
Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapyR Ophir, M Pecht, Y Keisari, et al.
Pageof 4